SOLENO THERAPEUTICS INC — Cash Flow Charts
13 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+268.5% +$75M
$47M
Free Cash Flow↑+268.1% +$75M
$47M
Investing Cash Flow↓-917086.4% -$202M
$-202M
Financing Cash Flow↑+107257.0% +$137M
$137M
Capex↑+231.8% +$51K
$73K
Acquisitions
$573K
Stock Buybacks
$100M
Stock-Based Comp↑+1299.5% +$43M
$46M
Debt Issued
$0
D&A↑+2.8% +$54K
$2M
SBC Allocated Expense↑+1299.5% +$43M
$46M